RVMD

Revolution Medicines, Inc.

Biotechnology · Biotechnology

$215.13 sample

+3.18 (+1.50%) 1D

Market cap

$874.8B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-21

Alerts

8

Price$215.13 +9.72% 3M daily closessample

215.13192.14

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider sell: Director
Sep 21SECDEF 14A filed
Sep 16SEC10-Q filed
Sep 08INSInsider sell: Chief Executive Officer
Aug 31INSInsider buy: Director
Aug 25INSInsider buy: EVP, Operations
Aug 18INSInsider sell: Chief Executive Officer
Aug 13INSInsider buy: Chief Executive Officer

Sign up to see the real RVMD record →

Company facts

SEC EDGAR registration

Name: Revolution Medicines, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -34sample, -100 to +100
Reporting currency: USD

Who is positioning in RVMD

sample

Insiders: 22 insider transactions over 90 days, net selling, $650.1M
Congress: 4 members traded over 90 days
Institutions · 13F: 18 funds hold $17.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$35.0B +17.2% y/y

Q4 2024Q3 2026

Inventory$21.7B +13.9% y/y

Q4 2024Q3 2026

Accounts receivable$16.2B +13.4% y/y

Q4 2024Q3 2026

Total debt$44.1B +12.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $541.0B +2.8% 3M
Sample peer B: $200.4B +12.7% 3M
Sample peer C: $723.9B +16.0% 3M
Sample peer D: $484.2B +3.9% 3M
Sample peer E: $488.4B +4.5% 3M